Le Lézard
Classified in: Science and technology
Subjects: TDS, HSP, FVT

Cybersecurity, AI And Blockchain To Take Center Stage At eMerge Americas 2018


MIAMI, March 14, 2018 /PRNewswire-USNewswire/ -- eMerge Americas, the premier technology event connecting Latin America, North America and Europe, today announced a number of sessions that will get at the heart of the hottest trends being discussed across industries: cybersecurity, AI and blockchain. Speakers include Andy Ellis, Chief Security Officer, Akamai; Sophia the Robot; César Cernuda, President, LatAm, Microsoft; Manny Medina, CEO, Cyxtera Technologies; and Jackie Hyland, Director, LatAm, Silicon Valley Bank.

Inspiration, Innovation, and a Nod to the Future Take Center Stage at eMERGE Americas 2016

"We have gathered some of the brightest minds in innovation to share how they are solving the world's most pressing business issues," said Xavier Gonzalez, CEO of eMerge Americas. "We are proud to connect startups, entrepreneurs, VCs, major businesses and government officials for an unparalleled opportunity to stand shoulder to shoulder with these visionary leaders and build powerful partnerships without borders."

CYBERSECURITY SESSIONS:

AI SESSIONS:

BLOCKCHAIN SESSIONS:

MESSAGES FROM THE MINES: AN INTERACTIVE INSTALLATION
New this year, attendees will have the opportunity to interact with a unique art installation. Messages from the Mines excavates and analyzes messages left in the Bitcoin blockchain by miners, and in doing so helps to disambiguate some of the misunderstood aspects of this new technology. These messages, left inside the blocks of the blockchain, are a form of digital graffiti, unique?though overlooked?cultural artifacts forever embedded in one of the most contemporary digital technologies.

Registration for eMerge Americas 2018 is now open, visit emergeamericas.com to register. For the latest eMerge Americas news, connect with us on Facebook, Twitter, LinkedIn (@eMergeAmericas) and Instagram (@emergeamericas).

About eMerge Americas
eMerge Americas serves as the preeminent innovative thought exchange transforming Miami into the technological hub of the Americas. By connecting global industry leaders and investors with America's top business executives, technology decisionmakers, and entrepreneurs, partnerships are forged that spur visionary innovation and technological advancements for the betterment of business and society. The eMerge Americas founding partners include: Medina Capital, A Rod Corporation, Greenberg Traurig, Knight Foundation, Miami-Dade County, and the Miami Herald. For more information about eMerge Americas, please visit: emergeamericas.com.

SOURCE eMerge Americas


These press releases may also interest you

at 04:05
True, the only tech and data-first global talent platform, today announced its partnership with Leadership Circle, a leading global provider of executive coaching, assessments, and advisory services. This collaboration marks a significant step for...

at 04:05
Veritonic, the industry's comprehensive audio research and analytics platform, announced today an integration with SaaS mobile marketing analytics and attribution platform, AppsFlyer. This integration empowers Veritonic's audio attribution solution...

at 04:00
Following the conclusion of a successful pilot, Cambridge University Press is expanding the rollout of Cassyni journal seminar series to more journals in their portfolio. The series enable Cambridge to grow researcher communities around its journals,...

at 04:00
Gcore, the global edge AI, cloud, network, and security solutions provider, today announced its recognition as 'Highly Commended' in the Industry Innovation category at the NVIDIA Partner Network Awards EMEA 2024 for its groundbreaking Speech-to-Text...

at 04:00
Today Benchling announced that Zealand Pharma A/S, ("Zealand") a biotechnology company focused on the discovery and development of peptide-based medicines, has selected the Benchling R&D Cloud as its central source of truth for scientific data,...

at 03:38
Medivir AB (STO: MVIR), a pharmaceutical company focused on developing innovative treatments for cancer in areas of high unmet medical need, announced today an update from a Type C meeting with the FDA, regarding the company's plans for a global...



News published on and distributed by: